Cargando…
Hepatotoxicity due to tocilizumab and anakinra in rheumatoid arthritis: two case reports
Elevation of liver enzymes in patients with rheumatoid arthritis treated with the biological agents, tocilizumab and anakinra, is now well documented. However, histological characterization of these effects and outcomes has not been defined. Here we report toxic liver effects in two women with rheum...
Autores principales: | Mahamid, Mahmud, Paz, Kalman, Reuven, Mader, Safadi, Rifaat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177591/ https://www.ncbi.nlm.nih.gov/pubmed/21941451 http://dx.doi.org/10.2147/IJGM.S23920 |
Ejemplares similares
-
Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions
por: Mahamid, Mahmud, et al.
Publicado: (2011) -
Anakinra/tocilizumab: Primary biliary cholangitis: case report
Publicado: (2021) -
Low Serum Lysosomal Acid Lipase Activity Correlates with Advanced Liver Disease
por: Shteyer, Eyal, et al.
Publicado: (2016) -
Could anakinra outmatch dexamethasone/tocilizumab in COVID-19?
por: Gupta, Rahul
Publicado: (2022) -
Anakinra and hepatotoxicity in pediatric rheumatology: a case series
por: Martins, Frederico Rajão, et al.
Publicado: (2023)